Deficient anterior pituitary with common variable immune deficiency (DAVID syndrome): a new case and literature reports
Authors:
- Thi Thom MacTMThi Thom Mac
- Frederic CastinettiFCFrederic Castinetti
- Marlene PasquetMPMarlene Pasquet
- Pauline RomanetPRPauline Romanet
- Alexandru SaveanuASAlexandru Saveanu
- Gregory MougelGMGregory Mougel
- Teddy FauquierTFTeddy Fauquier
- Nicolas JullienNJNicolas Jullien
- Anne BarlierABAnne Barlier
- Rachel ReynaudRRRachel Reynaud
Open Access
- 15 June 2023
- journal article
- research article
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 35 (6) , e13287
Abstract
Deficient anterior pituitary with common variable immune deficiency (DAVID) syndrome is a rare condition characterized by adrenocorticotropic hormone (ACTH) deficiency and primary hypogammaglobulinemia. It is due to heterozygous mutations of the nuclear factor kappa‐B subunit 2 (NFKB2) gene. Only a few isolated cases have been reported since its first description by our team. Through the international multicenter GENHYPOPIT network, we identified a new case of DAVID syndrome. We then conducted an extensive review of the DAVID syndrome cases published from 2012 to 2022. A 7‐year‐old boy was diagnosed with symptomatic hypoglycemia revealing ACTH deficiency. Laboratory tests showed asymptomatic hypogammaglobulinemia. He harbored a heterozygous point mutation in NFKB2 gene (c.2600C > T, p.Ala867Val). His management included hydrocortisone replacement treatment, and he also received subcutaneous immunoglobulins during the Covid‐19 pandemic. We analyzed 28 cases of DAVID syndrome with ACTH deficiency. ACTH deficiency was the only hormone deficiency in 79% of patients, but some patients harbored growth hormone (GH) and thyroid stimulating hormone (TSH) deficiencies. The first presenting symptoms were sinus/pulmonary infections (82%, mean age of 3 years) and alopecia (mean age of 4.7 years). ACTH deficiency was the third presenting condition (mean age at diagnosis of 8.6 years). All patients had hypogammaglobulinemia (decreased IgA and IgM levels), and 57% of patients had at least one autoimmune manifestation. Heterozygous mutations at the 3′end of the NFKB2 gene, coding for the C‐terminal domain of the protein, were identified in all cases. Better knowledge of DAVID syndrome will help clinicians make an early diagnosis to avoid life‐threatening complications.Keywords
This publication has 22 references indexed in Scilit:
- Mechanisms of genotype-phenotype correlation in autosomal dominant anhidrotic ectodermal dysplasia with immune deficiencyJournal of Allergy and Clinical Immunology, 2018
- Functional evaluation of natural killer cell cytotoxic activity in NFKB2-mutated patientsImmunology Letters, 2018
- Severe Toxoplasma gondii infection in a member of a NFKB2-deficient family with T and B cell dysfunctionClinical Immunology, 2017
- NFKB2 mutation in common variable immunodeficiency and isolated adrenocorticotropic hormone deficiencyMedicine, 2016
- Defective natural killer–cell cytotoxic activity in NFKB2-mutated CVID-like diseaseJournal of Allergy and Clinical Immunology, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Germline Mutations in NFKB2 Implicate the Noncanonical NF-κB Pathway in the Pathogenesis of Common Variable ImmunodeficiencyThe American Journal of Human Genetics, 2013
- Use and interpretation of diagnostic vaccination in primary immunodeficiency: A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & ImmunologyJournal of Allergy and Clinical Immunology, 2012
- Pituitary autoimmunity: 30 years laterAutoimmunity Reviews, 2008
- A Stroma-Derived Defect in NF-κB2−/− Mice Causes Impaired Lymph Node Development and Lymphocyte RecruitmentThe Journal of Immunology, 2004